SCHEMBL28006254

SCHEMBL28006254

CC(=O)Oc1ccnc2ncccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.55
▸ TDP1 Q9NUW8 2/20 0.55
▸ CYP3A4 P08684 2/20 0.55
▸ ALOX12 P18054 1/20 0.55
▸ PDE5A O76074 1/20 0.48
▸ BRD4 O60885 2/20 0.43
▸ SLC22A6 Q4U2R8 1/20 0.42
▸ PTPN1 P18031 1/20 0.42
▸ HTT P42858 2/20 0.41
▸ TSHR P16473 3/20 0.40
▸ ESR1 P03372 2/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ ITGB3 P05106 1/20 0.40
▸ ITGA2B P08514 1/20 0.40
▸ HMGB1 P09429 1/20 0.40
▸ HPGD P15428 1/20 0.40
▸ GGT1 P19440 1/20 0.40
▸ PTGS1 P23219 1/20 0.40
▸ PTGS2 P35354 1/20 0.40
▸ BLM P54132 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30511914 0.79 PTPN1 (0.51) KDM4ETDP1CYP3A4ALOX12SLC22A6
SCHEMBL13434056 0.79 PTPN1 (0.51) KDM4ETDP1CYP3A4ALOX12SLC22A6
SCHEMBL10488788 0.79 KDM4E (0.77) KDM4ETDP1CYP3A4ALOX12BRD4
SCHEMBL2882948 0.78 MEN1 (0.54) KDM4ETDP1CYP3A4ALOX12PDE5A
SCHEMBL19036712 0.76 SYK (0.49) KDM4EPDE5AADRA1A
SCHEMBL30940274 0.76 SYK (0.49) KDM4EPDE5AADRA1A
SCHEMBL3832725 0.75 CYP19A1 (0.47) KDM4ETDP1HTTTSHRALDH1A1
SCHEMBL14638135 0.75 KDM4E (0.57) KDM4ETDP1CYP3A4ALOX12PDE5A
SCHEMBL27516186 0.74 KDM4E (0.50) KDM4ETDP1CYP3A4ALOX12BRD4
SCHEMBL3362605 0.73 HTT (0.46) KDM4ETDP1CYP3A4ALOX12SLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104507913-A Antiproliferative benzo[b]azepin-2-ones HOFFMANN LA ROCHE 2015-04-08 — — CN disclosed
Send feedback